To ensure compliance with the EC Grant Agreement and Consortium Agreement, and to ensure that the projects agreed deliverables and milestones are achieved within budget, and on time. To this end, strict procedures have been installed and officialised in a Project Management Manual. Procedures entail production and dissemination of project documentation, meetings, achievement of milestones and deliverables and the budget
To ensure the effective inter-WP alignment of activities and promote efficient and effective internal communication and decision-making
To develop a feasible business plan for the sustainable continuation of the operational infrastructures and processes needed to continue the VALUE-Dx activities well beyond the projects 4-years, and to widen the applicability of study findings beyond the current priority of CA-ARTI in community care settings
In this insightful interview, we engage with Dr. Arjana Tambic, a leading expert in antimicrobial resistance from Zagreb, Croatia. Dr. Tambic brings extensive experience from her roles in national and international AMR surveillance and education as she shares her perspectives on the critical challenges posed by AMR, the importance of robust surveillance systems, and the essential role of rapid diagnostics in improving antibiotic prescribing practices.
https://www.value-dx.eu/wp-content/uploads/2024/07/Arjana-Tambic-photo-2021.png728649Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2024-07-31 07:58:102024-07-31 08:13:07Interview with Croatian AMR expert Arjana Tambic Andrasevic
https://www.value-dx.eu/wp-content/uploads/2024/04/Untitled-3.png9951488Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2024-04-22 11:33:552024-04-22 14:55:43PRUDENCE and ADEQUATE-paediatric studies: the final steps
Meet Dr. Füsun Can, a medical doctor and professor in Istanbul. She leads a multidisciplinary team focused on antibiotic resistance research. With expertise in virology and a commitment to collaborative efforts, Dr. Can’s work extends beyond the laboratory, aiming to address emerging infectious disease challenges across Turkey.
https://www.value-dx.eu/wp-content/uploads/2024/04/Picture-Fusun-scaled.jpg24542560Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2024-04-15 15:05:072024-04-16 13:50:39AMR expert interview with Dr. Füsun Can